A5043678766- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Gastric Cancer Management and Outcomes
- Colorectal and Anal Carcinomas
- Global Cancer Incidence and Screening
- Multiple and Secondary Primary Cancers
- Metabolism, Diabetes, and Cancer
- Cervical Cancer and HPV Research
- Head and Neck Cancer Studies
- Intraperitoneal and Appendiceal Malignancies
- Diverticular Disease and Complications
- Palliative Care and End-of-Life Issues
- Diabetes Treatment and Management
- Economic and Financial Impacts of Cancer
- Health Promotion and Cardiovascular Prevention
- Clinical practice guidelines implementation
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Helicobacter pylori-related gastroenterology studies
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
Netherlands Comprehensive Cancer Organisation
2015-2021
The Netherlands Cancer Institute
2020
Cancer Association of South Africa
2018
Erasmus MC
2015-2017
Erasmus University Rotterdam
2015
Regarding the continuous changes in diagnostic process and treatment of colorectal cancer (CRC), it is important to evaluate long‐term trends which are relevant giving direction for further research innovations patient care. The aim this study was analyze developments incidence, survival patients diagnosed with CRC Netherlands. For population‐based retrospective cohort study, all between 1989 2014 Netherlands were identified using data nationwide Cancer Registry ( n = 267,765), follow‐up...
Abstract Background Adequate MRI-based staging of early rectal cancers is essential for decision-making in an era organ-conserving treatment approaches. The aim this population-based study was to determine the accuracy routine daily MRI cancer, whether or not combined with endorectal ultrasonography (ERUS). Methods Patients cT1–2 cancer who underwent local excision total mesorectal (TME) without downsizing (chemo)radiotherapy between 1 January 2011 and 31 December 2018 were selected from...
With an estimated 13,000 newly diagnosed patients per year, nasopharyngeal carcinoma (NPC) is one of the most common types cancer in males Indonesia. Moreover, are at advanced stage disease. This study aimed to explore health behaviors with NPC and possible causes patient delay diagnosis. A qualitative research method was used gain better insight into behaviors. Twelve were interviewed using semi-structured interview guidelines. All interviews recorded, transcribed verbatim analyzed...
High-volume hospitals have been associated with improved patient outcomes for tumors a relatively low incidence that require complex surgeries, such as esophageal and pancreatic cancer. The volume-outcome association colorectal cancer is under debate.This study investigated whether hospital volume surgical care characteristics 5-year overall survival.This population-based study.Data were gathered from the Netherlands Cancer Registry. Hospitals grouped by colon (<50, 50-74, 75-99, ≥100...
Abstract Primary tumor location is an established prognostic factor in patients with (metastatic) colon cancer. Colon tumors can be divided into left‐sided and right‐sided tumors. The aim of this study was to determine the impact primary on treatment overall survival (OS) peritoneal metastases (PM) from This a retrospective, population‐based cohort study. Records diagnosed cancer synchronous PM, 1995 through 2016, were retrieved Netherlands Cancer Registry (NCR). Data diagnosis, staging,...
Background: Stigma refers to a distinctive, discrediting characteristic, rendering its bearer tainted or inferior by others. Definitions of stigma acknowledge the recognition difference; and devaluation. Evidence, largely from high-income countries suggests that cancer is stigmatized disease. Cancer-related not well-documented in South Africa, little known about how it impacts health-seeking behavior, treatment adherence, quality life psychosocial well-being patients. Limited research has...
3522 Background: In the past decade, reported median overall survival (mOS) in phase 3 trials of metastatic colorectal cancer (mCRC) patients increased from approximately 16 to over 36 months. However, only 2.5-20% participate clinical studies and these are often with favourable prognostic factors. Therefore, we explored for which proportion real-life stage IV CRC OS improved recent years. Methods: Nationwide population-based data all (synchronous metastatic) diagnosed between 2008-2016...
Cancer survivors with diabetes tend to have worse glycemic control after their cancer diagnosis, which may increase the risk of cardiovascular diseases. We aimed investigate whether differs between colorectal (CRC) and those without cancer, among patients type 2 being treated in Dutch primary care. The Zwolle Outpatient Diabetes project Integrating Available Care database was linked Registry (n = 71,648, 1998–2014). cases were stage 0–III CRC, controls history. secondary outcomes probability...